Nutritional and intestinal effects of the novel immunosuppressive agents: Deoxyspergualin, rapamycin, and mycophenolate mofetil
- 31 August 1996
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 29 (4) , 363-369
- https://doi.org/10.1016/0009-9120(96)00015-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- FK506 increases permeability in rat intestine by inhibiting mitochondrial functionGastroenterology, 1995
- Abdominal Multivisceral TransplantationTransplantation, 1995
- CONVERSION FROM CYCLOSPORINE TO FK506 FOR SALVAGE OF IMMUNOCOMPROMISED PEDIATRIC LIVER ALLOGRAFTS EFFICACY, TOXICITY, AND DOSE REGIMEN IN 23 CHILDRENTransplantation, 1994
- Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate MofetilImmunological Reviews, 1993
- THE IMMUNOPHARMACOLOGY OF IMMUNOSUPPRESSION BY 15-DEOXYSPERGUALINTransplantation, 1993
- THE EFFECTS OF CYCLOSPORINE ON NORMAL BOWELTransplantation, 1991
- Lymphocyte‐Selective Antiproliferative and Immunosuppressive Effects of Mycophenolic Acid in MiceScandinavian Journal of Immunology, 1991
- RS-61443—A NEW, POTENT IMMUNOSUPPRESSIVE AGENTTransplantation, 1991
- RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTINGThe Lancet, 1989
- SEGMENTAL SMALL INTESTINAL ALLOGRAFTS II. INADEQUATE FUNCTION WITH CYCLOSPORINE IMMUNOSUPPRESSIONTransplantation, 1987